Brett Haumann

Brett Haumann is a respected senior pharmaceutical executive with extensive experience in the biotechnology and pharmaceutical sectors. They have held leadership roles in preclinical and clinical discovery, project leadership, and alliance management, contributing to the development of new medicines and managing interactions with key regulatory agencies worldwide. Currently, Brett serves as the Chief Executive Officer of RIGImmune Inc. and as a Non-Executive Director at Aravax, while also consulting for Caducean Limited in the pharmaceutical and biotechnology industry. Their background includes notable positions such as Chief Medical Officer at Theravance Biopharma and GSK, along with a Master's in Business Administration from The Open University.